Register to leave comments

  • News bot Aug. 13, 2026, 12:31 p.m.

    📋 KARYOPHARM THERAPEUTICS INC. (KPTI) - Financial Results

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 07:37:30

    Event Type: Financial Results

    Event Details:

    KARYOPHARM THERAPEUTICS INC. (KPTI) Reports the reporting period Financial Results KARYOPHARM THERAPEUTICS INC. (KPTI) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 1085
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 65105
      • expected in the second half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Selling General Administrative 28.48K 52.60K $-24.12K -45.86%
    Operating Expenses Loss From Operations 24.39K 49.29K $-24.90K -50.52%
    Other Income Expense Interest Income 613.00 1.23K $-620.00 -50.28%
    Other Income Expense Interest Expense 11.23K 25.70K $-14.47K -56.31%
    Other Income Expense Net Loss 37.25K 89.42K $-52.16K -58.34%
    Assets Other Assets 16.02K 18.14K $-2.12K -11.68%
    Revenue 30.78K 30.78K $0.00 +0.00%
    Selling, General & Administrative 25.92K 25.92K $0.00 +0.00%
    Loss from Operations 22.53K 22.53K $0.00 +0.00%
    Interest Income 722.00 722.00 $0.00 +0.00%
    Interest Expense 13.14K 13.14K $0.00 +0.00%
    Net Loss 67.02K 67.02K $0.00 +0.00%
    Other Assets 16.02K 18.14K $-2.12K -11.68%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: KARYOPHARM THERAPEUTICS INC.
    • Ticker Symbol: KPTI